Call for Abstract
21st Asia Pacific Diabetes Conference , will be organized around the theme “Lifestyle modifications and Management strategies for the prevention of diabetes”
Diabetes Asia Pacific 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diabetes Asia Pacific 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
The incidence rate of diabetes is exceptionally high across the globe, fuelled by reducing physical activities and unhealthy diet. According to IMARC’s report, compared to Type-1 diabetes, Type-2 diabetes represents the more prevalent type, accounting for the majority of all diagnosed diabetes cases. Urban areas dominate rural areas in the number of diabetes patients and females presently account for the majority of the total diabetes patients. Despite the general down climate of the economy and healthcare, there has been great progress in the advancement of diabetes knowledge, treatment and prevention in recent years. This progress continues of a daily basis, with scientific advances being announced at an exponential rate. New therapeutic products are being introduced regularly and the pipeline is now full of new diabetes therapeutics in development. Never before, in the history of medicine, has the outlook for diabetes treatment and prevention looked so promising. The diabetes drugs segment dominated the endocrinology drugs market and accounted for more than 86% of the market share during 2015. At an annual growth rate (CAGR) of 4.4%, from 2016 to 2021, World diabetes market projected to reach $155 billion by 2021 from $125 billion. Follow Endocrinology Conferences and Diabetes Conferences for more updates.
- Track 1-1Insulin secretagogues
- Track 1-2Insulin sensitizers
- Track 1-3Diabetes therapy
- Track 1-4Glucose absorption inhibitors(Sodium–Glucose Co-Transporter (SGLT-1 and 2) Inhibitors)
- Track 1-5Glucagon-Like Peptide-1 (GLP-1) analogues (Lixisenatide)
- Track 1-6Dipeptidyl Peptidase-IV (DPP IV) Inhibitors
- Track 1-7Novel lyophilized hydrogel patches (Convenient insulin administration)
- Track 1-8Glucokinase Activators
- Track 1-9Insulin analogues & Insulin pumps
Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes the majority of genetic risk of diabetes remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies.
- Track 2-1Diabetes Hereditary
- Track 2-2Diet
- Track 2-3Obesity
- Track 2-4Metabolic Syndrome
- Track 2-5Insulin Resistance
- Track 2-6Measles
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.
- Track 3-1Diabetic Cardiomyopathy
- Track 3-2Diabetic Retinopathy
- Track 3-3Prediabetes
- Track 3-4Increased thirst
- Track 3-5Frequent urination
- Track 3-6Extreme hunger
- Track 3-7Unexplained weight loss
Endocrine disorders can be classified according to the intensity of hormonal activity and according to the origin of endocrine disorder. From the intensity of hormonal activity of endocrine gland we can distinguish hyper function of endocrine gland, which is characterized by increased secretion of its hormone as well as by increased concentration of this hormone in circulating blood. If endocrine gland produces several kinds of hormones the symptoms resulting from hyper production or hypo production of more kinds of hormones may develop, respectively, at the same time the symptoms of hyper function resulting from overproduction of one kind of hormones and the symptoms of hypo function due to a deficiency of other kind of hormones can develop. Refunction of endocrine gland, which is in the time of medical examination characterized by normal secretion of its hormone as well as by normal concentration of this hormone in circulating blood. Endocrine disease results when a gland produces too much or too little of an endocrine hormone called as hormone imbalance.
- Track 4-1Hormones and diabetes complications
- Track 4-2Thyroid and thymus
- Track 4-3Pituitary and pineal glands
- Track 4-4Primary aldosterone’s
- Track 4-5Pheochromocytoma
- Track 4-6Hyperprolactinemia
- Track 4-7Pituitary and pineal glands
Diabetes mellitus type 2 is an epidemic health problem, affecting more than 150 million people worldwide. This number is expected to double in the first decades of the third millennium. Recently, evidence for reduction of complications of type 2 diabetes with tight control of hyperglycaemia has been reported, but current therapies, including diet, exercise, behaviour modification, oral hypoglycaemic agents, and insulin, rarely return patients to euglycemia. Morbid obesity, in which patients exceed their ideal weight by at least 100 lb or are more than 200% of ideal body weight, is a condition with high mortality and morbidity because of its association with severe comorbid diseases such as hypertension, diabetes, hyperlipidaemia, and cardiopulmonary failure. In these patients, surgery represents the most effective therapy in that it achieves significant and durable weight loss as well as resolution or amelioration of comorbidities. Current indications for surgery in morbidly obese patients include body mass index (BMI) greater than 40 or greater than 35 if comorbidities are present.
- Track 5-1Bariatric surgeries
- Track 5-2Metabolic surgeries
- Track 5-3Sleeve gastrectomy
- Track 5-4Vascular Surgery
A clinical trial is an approach to precisely test another medication or gadget in patients before it is endorsed by the FDA to be utilized in public. Clinical trials are an important and critical step in our having the capacity to have new medications for diabetes and other varied conditions. A case study is a methodology and a strategy that investigates a phenomenon with its real-life context. Case studies and clinical trials are used to develop or assess the quality of the medications being developed.
- Track 6-1Clinical diagnosis and laboratory tests
- Track 6-2Diabetes, Prediabetes and Metabolic Syndrome
- Track 6-3Clinical trials on animal models
- Track 6-4Novel research and treatment strategies on diabetes
- Track 6-5Clinical case reports and clinical endocrinology practices
- Track 6-6Novel Paradigms in Diabetic Complications
- Track 6-7Clinical presentation and diagnosis of diabetes mellitus in adults
Diet and physical fitness are imperative parts of a sound way of life when you have diabetes. Alongside different advantages, following a healthy balanced diet and being dynamic can enable you to keep your blood glucose level in your objective range. To deal with your blood glucose, you must adjust with what you eat and drink along with physical movement and medications. The quantity and quality of food that you eat, and when you eat are extremely vital in keeping your blood glucose level in the range that your healthcare professional suggests.
- Track 7-1Exercise for diabetics
- Track 7-2Diet for Diabetics
- Track 7-3Nutrition for Diabetics
- Track 7-4Protein intake and Diabetes
- Track 7-5Food combinations and diabetes
- Track 7-6Lifestyle Intervention and Diabetes Prevention
Gestational diabetes is diabetes that occurs during pregnancy in women. Gestational diabetes occurs in about 4% of all pregnancies. It is usually diagnosed at any stages of pregnancy but is more common in the second half and occurs in women who have no prior history of diabetes. In most cases Gestational diabetes is picked up when blood sugar level is tested during screening. Some women may develop symptoms if their blood sugar level becomes too high. This may lead to difficulties during the delivery and increases the chances of needing a caesarean section. Follow Diabetes Conferences for more details
- Track 8-1Placental Hormones
- Track 8-2Genetics of Diabetes
- Track 8-3Prediabetes
- Track 8-4Etiology and pathogenesis
- Track 8-5Managing self-care
- Track 8-6Prognosis
- Track 8-7Monitoring fatal growth and well-being
Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidaemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidaemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned.
- Track 9-1Diabetes Research
- Track 9-2Diabetes and cancer
- Track 9-3Obesity
- Track 9-4Type 1 Diabetes
- Track 9-5Type 2 Diabetes
- Track 9-6Diabetic dyslipidaemia
In every of these cases, using one's own stem cells will facilitate the exocrine gland regenerate and boost its ability to produce insulin. Procedure continues to achieve success, with patients experiencing health advantages even six months after stem cell diabetes treatment. repeated applications of adipose stem cells is that the most effective treatment for diabetes type two, providing an open window to create dietary changes, supplementation and exercise much more effective for long-term management of blood glucose. Adult stem cells, undifferentiated and adaptable, area unit ready to transform into the cells of innumerable organs and structures inside the body.Swiss Medical Clinic has developed the Adult autologous stem cell medical care program to treat a range of conditions. Throughout stem cell treatment a patient receives 200 – 300 million stem cells. The number of restored cells not only covers daily losses, however exceeds them 1000 times. Thus, the reserve of the stem cells, much lost for the newest 15 – 20 years, is restored. When such active cell filling, organ gets rejuvenated and revived, because the new and active cells displace the previous and broken ones.
- Track 10-1Stem Cell Therapy
- Track 10-2Treatment of Diabetes
- Track 10-3Embryonic Stem Cell Research
- Track 10-4Type 1 Diabetes Beta Cells
- Track 10-5Umbilical Stem Cells
- Track 10-6Stem Cells and Diabetes
Endocrinology is a perplexing investigation of the different hormones and their activities and disarranges in the body. Endocrine Glands are organs that make hormones. These are substances that control exercises in the body and effectively affect the digestion system, multiplication, nourishment retention and use, development and improvement and so on. Hormones likewise control the way a living being reacts to their environment and help by giving sufficient vitality to different capacities. Diabetes is brought about by diminished creation of insulin or by diminished capacity to utilize insulin. Insulin, the hormone delivered by the beta cells in the pancreas, permits (glucose) cells to have the capacity to utilize glucose. This hormone is fundamental for glucose to go from the blood to within the body cells. With deficient insulin, glucose develops in the circulatory system as opposed to going into the cells. The body can't utilize glucose for vitality in spite of the elevated amounts of glucose in the circulatory system. This causes the unreasonable thirst, pee, and appetite, which are the most widely recognized side effects of diabetes. The abundance sugar stays in the blood and is then evacuated by the kidneys. This sickness happens in a few structures, yet the most well-known are Type I Diabetes or Juvenile Onset Diabetes or Insulin-Dependent Diabetes Mellitus (IDDM), Type II or Non-Insulin Dependent Diabetes Mellitus (NIDDM), and Gestational.
- Track 11-1Congenital adrenal hyperplasia (CAH)
- Track 11-2Graves’ disease
- Track 11-3Hypoglycaemia
- Track 11-4Hyperthyroidism
- Track 11-5Hypothyroidism
- Track 11-6Osteoporosis
Public health protects and promotes the health of the people where they live. Public health professionals aim to prevent people living in communities from falling ill and create awareness among them to encourage healthy atmosphere. Vaccinating children to avoid spread of disease, educating them in terms of risk factors and preventive measures, developing nutritional programs etc. are carried out by people in public health departments. They also shed light on why few communities of people are more prone to a disease than others.
Nanotechnology holds a great deal of promise for the world of medicine. It is likely that some of the first truly revolutionary changes noticeable in our everyday lives will be brought about by nanomedicine. the possibilities of nanomedicine include Nano formulations for efficient drug delivery, smart drugs which only activate when needed, engineered microbes which produce human hormones, and even "Nano robots", which would move autonomously around the body acting as a boost, or a replacement, for our immune system, red blood cells, or many other biological systems. Whilst many of these applications of nanotechnology as a long way off, there is a great deal of active research into medical technology - much of which is not very far-fetched. This article explores the way in which nanotechnology could be used to effectively treat, and possibly cure, diabetes - in particular Type 1 diabetes.
- Track 13-1Nanomedicine
- Track 13-2Applications of Nanotechnology for Diabetes Management
- Track 13-3Oral Insulin
- Track 13-4Monitoring Glucose Levels
- Track 13-5Potential Long-Term Treatments or Cures for Diabetes
- Track 13-6Nano porous Immunoisolation Devices
- Track 13-7Artificial Pancreas
Diabetic Nephropathy is the chronic loss of functioning of the kidneys occurring in those with diabetes. This is also known as End-Stage Renal Disease (ESRD). Not everyone with diabetes has kidney failure, around 40% of people with diabetes can develop nephropathy. Usual symptom is frequent urination, urine usually doesn’t contain protein albumin, but in some cases your kidneys are not able to filter the protein out the way they should and then the problem is diagnosed as diabetic nephropathy
- Track 14-1Pathophysiology of Diabetic Nephropathy
- Track 14-2Complications of Diabetic Nephropathy
Type 1 diabetes is a serious type of condition. It is also known as insulin-dependent diabetes. It's occasionally called "adolescent" diabetes, since Type 1 diabetes occurs more often in kids and young people. However, it can occur at any age. It is an autoimmune disease because the body’s immune system attacks its own pancreas and destroys its islet cells. These cells are responsible for producing insulin and maintaining the blood sugar levels in the body. Without insulin, the high sugars in the blood can damage eyes, nerves, heart, kidneys and other parts of the body.
Type 2 diabetes is a common condition that causes the level of sugar (glucose) in the blood to become too high. It can cause symptoms like excessive thirst, needing to pee a lot and tiredness. It can also increase your risk of getting serious problems with your eyes, heart and nerves. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines and have regular check-ups. It's caused by problems with a chemical in the body (hormone) called insulin. It's often linked to being overweight or inactive, or having a family history of type 2 diabetes.
Thyroid malignancy is a metastatic tumour of the thyroid organ. It is similarly unprecedented contrasted with different tumours. Inside USA, it is figured that in 2016 near 64,000 new patients will be determined to have thyroid growth, contrasted with in excess of 240,000 patients with bosom malignancy and 135,000 patients with colorectal tumour. Be that as it may, less than 2,000 patients kick the bucket of thyroid tumour every year. In 2013 more than 630,000 patients were living with thyroid tumour inside USA. Ongoing epidemiological information from WHO recommends that there are in excess of 750 million cases all around with a thyroid issue. Expanding centre by government associations and private organizations like WHO and pharmaceutical organizations, to make consciousness of thyroid lack is fuelling the market development. Levothyroxine and Cytomel are the most offering drugs in the thyroid insufficiency treatment advertise. Take after Endocrinology Conferences and Diabetes Conferences for more updates.
- Track 16-1Hormones and diabetes complications
- Track 16-2Thyroid and thymus
- Track 16-3Primary aldosterone’s
- Track 16-4Hyperprolactinemia
The endocrine system is a system of organs that deliver and discharge hormones that assistance control numerous vital body capacities, including the body's capacity to change calories into vitality that forces cells and organs. The endocrine framework impacts how your heart pulsates, how your bones and tissues develop, even your capacity to make an infant. It assumes an indispensable part in regardless of whether you create diabetes, thyroid malady, development issue, sexual brokenness, and a large group of other hormone-related scatters.
- Track 17-1Placental Endocrinology
- Track 17-2Ovarian Disorders
- Track 17-3Gestational Diabetes- Treatment and care
- Track 17-4Low Testosterone
- Track 17-5Hyperandrogenism in women
- Track 17-6Endocrinology of fertility
- Track 17-7Hormonal Changes and its effects
The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace. come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed, regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.
- Track 18-1New Discoveries and Emerging Therapies for Type 1 Diabetes
- Track 18-2New Discovery and Treatment for Type 2 Diabetes
- Track 18-3New Therapeutic Mechanisms for Diabetes
- Track 18-4Other advanced medical technologies used in hospitals
- Track 18-5Exploring novel therapies in diabetes treatment